Natural killer cell-based immunotherapy for acute myeloid leukemia
Despite considerable progress has been achieved in the treatment of acute myeloid leukemia over the past decades, relapse remains a major problem. Novel therapeutic options aimed at attaining minimal residual ...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Jing Xu and Ting Niu Tags: Review Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Hematology | Immunotherapy | Leukemia